Close Menu

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced on Thursday that it has received CE-IVD marking for a qPCR assay to detect both Neisseria gonorrhoeae and sequences in the gyrA gene of the bacteria linked to ciprofloxacin susceptibility.

According to SpeeDx, the Resistance GC assay will allow doctors to confidently and cost-effectively treat up to 70 percent of gonorrhea infections with a single oral dose of ciprofloxacin.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.